Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dalfampridine1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
2Dalfampridine ER1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
3Dalfampridine ER, 10 MG oral tablet, extended release1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
4Dalfampridine plus physical therapy1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
5Dalfampridine-ER 10MG1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
6Dalfampridine-ER 5MG1件: Dalfampridine (Dalfampridine)1件: Dalfampridine (Dalfampridine, DALFAMPRIDINE) 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
7Sustained-release oral dalfampridine----1件: 13 💬
8Withdrawal OF dalfampridine-ER 10MG----1件: 13 💬